Fundamentals XERS (NASDAQ) - Xeris Pharmaceuticals Inc
VR Fundamental Rating -3.59
| VR Piotroski Score | 3.00 |
| Altman-Z Score | -1.68 |
| Tobins Q Ratio | - |
| Tax Rate | -58.06% |
| Free-Cash-Flow Yield | -21.02% |
| Free-Cash-Flow Margin | -67.05% |
| Net Margin | -64.08% |
| Gross Margin | 82.14% |
| Current Ratio | 2.03 |
| Debt / Equity | 6.29 |
| Debt / EBITDA | -3.45 |
| Debt / Free-Cash Flow | -2.32 |
| Interest Expense / Debt | 9.53% |
| RoE Return on Equity | - |
| RoCE Return on Cap. Employed | -27.57% |
| RoA Return on Assets | -24.20% |
| RoIC Return on Inv. Cap. | -42.44% |
| Analysts Rating | 4.50 |
| Analysts Target Price (is above last close by |
5.00 USD 77.3%) |
VR Piotroski 3.00
1 - No: Net Income TTM (-77.8m) > 10m and > 3% of Revenue TTM (3% = 3.6m)
2 - No: FCF TTM (-81.4m) > 1m and > FCF prev (98%) (-118.2m)
3 - No: RoA TTM -24.2% (Net Income TTM -77.8m / Total Assets 321.4m) >3% and > RoA prev (98%) -35.62% (-122.7m / 337.6m)
4 - No: Total Cash from Operating Activities TTM -80.6m > 1m and > Net Income TTM -77.8m
5 - Error: Net Debt/EBITDA cant be calculated
6 - Yes: Current Ratio 2.03 (Total Current Assets 165.5m / Total Current Liabilities 0.0m) >= 1 and > Current Ratio prev (98%) 1.8 (142.6m / 79.0m)
7 - No: Shares Outstanding last quarter 137.1m < quarter 12m ago 135.0m
8 - Yes: Gross Margin 82.14% (Total Revenue 121.4m - Cost Of Revenue 21.7m / Total Revenue) > 20% and > Gross Margin prev (98%) 70.66%
9 - Yes: Asset Turnover 0.38 (Total Revenue 121.4m / Total Assets 321.4m) > Asset Turnover prev (98%) 0.18 (63.7m / 337.6m)
10 - No: Interest Coverage Ratio None (EBITDA -54.8m / Interest Expense 18.0m) > 5
2 - No: FCF TTM (-81.4m) > 1m and > FCF prev (98%) (-118.2m)
3 - No: RoA TTM -24.2% (Net Income TTM -77.8m / Total Assets 321.4m) >3% and > RoA prev (98%) -35.62% (-122.7m / 337.6m)
4 - No: Total Cash from Operating Activities TTM -80.6m > 1m and > Net Income TTM -77.8m
5 - Error: Net Debt/EBITDA cant be calculated
6 - Yes: Current Ratio 2.03 (Total Current Assets 165.5m / Total Current Liabilities 0.0m) >= 1 and > Current Ratio prev (98%) 1.8 (142.6m / 79.0m)
7 - No: Shares Outstanding last quarter 137.1m < quarter 12m ago 135.0m
8 - Yes: Gross Margin 82.14% (Total Revenue 121.4m - Cost Of Revenue 21.7m / Total Revenue) > 20% and > Gross Margin prev (98%) 70.66%
9 - Yes: Asset Turnover 0.38 (Total Revenue 121.4m / Total Assets 321.4m) > Asset Turnover prev (98%) 0.18 (63.7m / 337.6m)
10 - No: Interest Coverage Ratio None (EBITDA -54.8m / Interest Expense 18.0m) > 5
Altman-Z -1.68
A = 0.262 = (Total Current Assets 165.5m - Total Current Liabilities 81.4m) / Total Assets 321.4m
B = -1.779 = Retained Earnings -571.6m / Total Assets 321.4m
C = -0.206 = EBIT TTM -66.1m / Total Assets 321.4m
D = 1.329 = Market Cap 387.2m / Total Liabilities 291.3m
E = 0.378 = Revenue TTM 121.4m / Total Assets 321.4m
-1.68 = (1.2 * A) + (1.4 * B) + (3.3 * C) + (0.6 * D) + (1.0 * E)
B = -1.779 = Retained Earnings -571.6m / Total Assets 321.4m
C = -0.206 = EBIT TTM -66.1m / Total Assets 321.4m
D = 1.329 = Market Cap 387.2m / Total Liabilities 291.3m
E = 0.378 = Revenue TTM 121.4m / Total Assets 321.4m
-1.68 = (1.2 * A) + (1.4 * B) + (3.3 * C) + (0.6 * D) + (1.0 * E)
Current Fundamental Values
Market Cap = 387.2m USD
Market Cap in USD = 387.2m (387.2m USD * 1 USDUSD)
Revenue TTM = 121.4m
Debt = 189.1m (short 1.448m + long 187.623m) last quarter
CCE = unknown 'cashAndEquivalents'
Enterprise Value = 576.3m (Market Cap 387.2m + Debt 189.1m - CCE 0m)
Net Debt = 189.1 (189.1m Debt - 0m Cash and Cash Equilavents)
EBITDA = -54.8m (TTM)
FCF Yield = -21.02% (FCF TTM -81.4m / Market Cap 387.2m)
FCF Margin = -67.05% (FCF TTM -81.4m / Revenue TTM 121.4m)
Net Margin = -64.08% (Net Income TTM -77.8m / Revenue TTM 121.4m)
Gross Margin = 82.14% ((Revenue TTM 121.4m - Cost of Revenue TTM 21.7m) / Revenue TTM 121.4m)
Tobins Q-Ratio = extreme level -0.177 (Market Cap 387.2m / Book Value Of Equity -2188.3m
Interest Expense / Debt = 9.53% (Interest Expense TTM 18.02m / Debt 189.1m)
Interest Coverage Ratio = None (EbitDA TTM -54.75m) / Interest Expense TTM 18.02m)
Taxrate = -58.06% last quarter (Income Tax Expense 9.77m / Income Before Tax -16.83m)
nopat = unkown (Taxrate is negative or null: -0.58)
Current Ratio = 2.03 (Total Current Assets 165.5m / Total Current Liabilities 81.42m)
Debt / Equity = 6.29 (Debt 189m / last Quarter total Stockholder Equity 30m)
Debt / EBITDA = -3.45 (Debt 189m - Cash and Cash Equivalents 0m / EBITDA -54m)
Debt / FCF = -2.32 (Debt 189m / FCF TTM -81m)
RoA = -24.20%
RoE = -258.9% (Net Income TTM -77m / Total Stockholder Equity 30m)
RoCE = -27.57% (Ebit TTM -66.14m / x)
RoIC = -42.44% (Ebit TTM -66.14m / (Total Assets 321.4m - Total Current Assets 165.5m) )
WACC = 13.78% ((Market Cap / EV) * CAPM 0.13) + (Debt / EV) * Interest Expense on Debt * (1 - Taxrate)
Shares Correlation 10y: 0.00 - Cagr: 48.64% (0.00)
EPS Kendall: 75.90 - EPS Cagr: 16.02% (12.16)
Rev Kendall: 91.08 - Rev Cagr: 0.00% (0.00)
Market Cap in USD = 387.2m (387.2m USD * 1 USDUSD)
Revenue TTM = 121.4m
Debt = 189.1m (short 1.448m + long 187.623m) last quarter
CCE = unknown 'cashAndEquivalents'
Enterprise Value = 576.3m (Market Cap 387.2m + Debt 189.1m - CCE 0m)
Net Debt = 189.1 (189.1m Debt - 0m Cash and Cash Equilavents)
EBITDA = -54.8m (TTM)
FCF Yield = -21.02% (FCF TTM -81.4m / Market Cap 387.2m)
FCF Margin = -67.05% (FCF TTM -81.4m / Revenue TTM 121.4m)
Net Margin = -64.08% (Net Income TTM -77.8m / Revenue TTM 121.4m)
Gross Margin = 82.14% ((Revenue TTM 121.4m - Cost of Revenue TTM 21.7m) / Revenue TTM 121.4m)
Tobins Q-Ratio = extreme level -0.177 (Market Cap 387.2m / Book Value Of Equity -2188.3m
Interest Expense / Debt = 9.53% (Interest Expense TTM 18.02m / Debt 189.1m)
Interest Coverage Ratio = None (EbitDA TTM -54.75m) / Interest Expense TTM 18.02m)
Taxrate = -58.06% last quarter (Income Tax Expense 9.77m / Income Before Tax -16.83m)
nopat = unkown (Taxrate is negative or null: -0.58)
Current Ratio = 2.03 (Total Current Assets 165.5m / Total Current Liabilities 81.42m)
Debt / Equity = 6.29 (Debt 189m / last Quarter total Stockholder Equity 30m)
Debt / EBITDA = -3.45 (Debt 189m - Cash and Cash Equivalents 0m / EBITDA -54m)
Debt / FCF = -2.32 (Debt 189m / FCF TTM -81m)
RoA = -24.20%
RoE = -258.9% (Net Income TTM -77m / Total Stockholder Equity 30m)
RoCE = -27.57% (Ebit TTM -66.14m / x)
RoIC = -42.44% (Ebit TTM -66.14m / (Total Assets 321.4m - Total Current Assets 165.5m) )
WACC = 13.78% ((Market Cap / EV) * CAPM 0.13) + (Debt / EV) * Interest Expense on Debt * (1 - Taxrate)
Shares Correlation 10y: 0.00 - Cagr: 48.64% (0.00)
EPS Kendall: 75.90 - EPS Cagr: 16.02% (12.16)
Rev Kendall: 91.08 - Rev Cagr: 0.00% (0.00)